Search This Blog

Wednesday, August 7, 2019

Ra Pharmaceuticals EPS misses by $0.03

Ra Pharmaceuticals (NASDAQ:RARX): Q2 GAAP EPS of -$0.52 misses by $0.03.
Cash and cash equivalents of $173.6M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)